Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 known ✓ | P09211 | 1/20 | 0.36 |
| ▸ | GSR | P00390 | 1/20 | 0.36 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.36 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.36 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56172 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL7105974 | 0.90 | GSR (0.36) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| SCHEMBL916303 | 0.90 | GSR (0.36) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| Fluoride SCHEMBL915482 | 0.90 | — | — | |
| Methane SCHEMBL88300 | 0.90 | — | — | |
| Water SCHEMBL8171778 | 0.90 | — | — | |
| SCHEMBL14716520 | 0.86 | KDM4E (0.43) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| Water SCHEMBL4930788 | 0.86 | KDM4E (0.40) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| Water SCHEMBL9057534 | 0.86 | KDM4E (0.40) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| Water SCHEMBL19019782 | 0.86 | KDM4E (0.40) | GSRGSTP1TXNRD1TXNRD3TXNRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230279244-A1 | RESIN COMPOSITION, COATED AND DRIED PRODUCT, MELT-KNEADED PRODUCT, OPTICAL FILTER, IMAGE DISPLAY DEVICE, SOLID-STATE IMAGING ELEMENT, SQUARYLIUM COMPOUND, AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2023-09-07 | — | — | US | disclosed |
| US-11342504-B2 | Oxocarbon-, pseudooxocarbon- and radialene compounds and their use | NOVALED GMBH (DE) | 2022-05-24 | — | — | US | disclosed |
| US-20200152873-A1 | Oxocarbon-, Pseudooxocarbon- and Radialene Compounds and Their Use | NOVALED GMBH (DE) | 2020-05-14 | — | — | US | disclosed |
| US-10586926-B2 | Oxocarbon-, pseudooxocarbon- and radialene compounds and their use | NOVALED GMBH (DE) | 2020-03-10 | — | — | US | disclosed |
| EP-3319940-B1 | NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME | UNIV BRAUNSCHWEIG TECH (DE) | 2019-05-29 | — | — | EP | disclosed |
| US-10287271-B2 | Indole compounds having antiprotozoal activity and its use as well as methods for producing the same | TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) | 2019-05-14 | — | — | US | disclosed |
| US-20180194750-A1 | NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME | TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) | 2018-07-12 | — | — | US | disclosed |
| EP-3319940-A1 | NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME | Technische Universität Braunschweig (DE) | 2018-05-16 | — | — | EP | disclosed |
| US-20180076389-A1 | Oxocarbon-, Pseudooxocarbon- and Radialene Compounds and Their Use | NOVALED GMBH (DE) | 2018-03-15 | — | — | US | disclosed |
| US-9876172-B2 | Oxocarbon-, pseudooxocarbon- and radialene compounds and their use | NOVALED GMBH (DE) | 2018-01-23 | — | — | US | disclosed |
| US-8617426-B2 | Oxocarbon-, pseudooxocarbon- and radialene compounds and their use | NOVALED AG (DE) | 2013-12-31 | — | — | US | disclosed |
| US-20110309309-A1 | Oxocarbon-, Pseudooxocarbon- and Radialene Compounds and Their Use | NOVALED AG (DE) | 2011-12-22 | — | — | US | disclosed |
| US-7981324-B2 | Oxocarbon-, pseudooxocarbon- and radialene compounds and their use | NOVALED AG (DE) | 2011-07-19 | — | — | US | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
| US-20080265216-A1 | Use as doping agent for doping organic semiconductive matrix material, as blocker material, as charge injection layer, as electrode material as well as organic semiconductor, electronic component; 1,3-Bi(dicyanomethylene)indane-2-ylidene-bis(4-oxo-[3,5-di-t-butyl]-2,5-cyclohexadienylidene)cyclopropane | NOVALED AG (DE) | 2008-10-30 | — | — | US | disclosed |
| US-7242542-B2 | Filters of electronic displays | KYOWA HAKKO CHEMICAL CO., LTD. (JP) | 2007-07-10 | — | — | US | disclosed |
| CN-1320378-C | Filter for electronic display device | KYOWA HAKKO CHEMICAL CO LTD (JP) | 2007-06-06 | — | — | CN | disclosed |
| US-20060063864-A1 | Filters of electronic displays | KYOWA HAKKO CHEMICAL CO., LTD (JP) | 2006-03-23 | — | — | US | disclosed |
| CN-1659456-A | Filter for electronic display device | KYOWA HAKKO CHEMICAL CO LTD (JP) | 2005-08-24 | — | — | CN | disclosed |
| EP-1521107-A1 | FILTERS FOR ELECTRONIC DISPLAYS | Kyowa Hakko Chemical Co., Ltd. (JP) | 2005-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | GSTP1 1960/4885GSR 356/4885TXNRD1 1263/4885 |
| US-20180076389-A1 | Oxocarbon-, Pseudooxocarbon- and Radialene Compounds and Their Use | DNMT3B, CHRNB1, CHRNB2 | GSTP1 4639/4885GSR 4686/4885TXNRD1 4452/4885 |
| US-20180194750-A1 | NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME | IDO1, IDO2, INMT | GSTP1 849/4885GSR 347/4885TXNRD1 1717/4885 |
| US-20200152873-A1 | Oxocarbon-, Pseudooxocarbon- and Radialene Compounds and Their Use | DNMT3B, CHRNB1, CHRNB2 | GSTP1 4639/4885GSR 4686/4885TXNRD1 4452/4885 |
| US-10586926-B2 | Oxocarbon-, pseudooxocarbon- and radialene compounds and their use | DNMT3B, CHRNB1, CHRNB2 | GSTP1 4639/4885GSR 4686/4885TXNRD1 4452/4885 |
| US-10287271-B2 | Indole compounds having antiprotozoal activity and its use as well as methods for producing the same | IDO1, IDO2, INMT | GSTP1 788/4885GSR 474/4885TXNRD1 1924/4885 |
| US-20230279244-A1 | RESIN COMPOSITION, COATED AND DRIED PRODUCT, MELT-KNEADED PRODUCT, OPTICAL FILTER, IMAGE DISPLAY DEVICE, SOLID-STATE IMAGING ELEMENT, SQUARYLIUM COMPOUND, AND METHOD FOR PRODUCING THE SAME | KLK5, KLHDC2, TNFRSF9 | GSTP1 4165/4885GSR 4615/4885TXNRD1 3826/4885 |
| US-11342504-B2 | Oxocarbon-, pseudooxocarbon- and radialene compounds and their use | DNMT3B, CHRNB1, CHRNB2 | GSTP1 4639/4885GSR 4686/4885TXNRD1 4452/4885 |
| US-20110309309-A1 | Oxocarbon-, Pseudooxocarbon- and Radialene Compounds and Their Use | DNMT3B, CHRNB1, CHRNB2 | GSTP1 4639/4885GSR 4686/4885TXNRD1 4452/4885 |
| US-20080265216-A1 | Use as doping agent for doping organic semiconductive matrix material, as blocker material, as charge injection layer, as electrode material as well as organic semiconductor, electronic component; 1,3-Bi(dicyanomethylene)indane-2-ylidene-bis(4-oxo-[3,5-di-t-butyl]-2,5-cyclohexadienylidene)cyclopropane | CHRNB1, GJB2, CHRNB3 | GSTP1 4484/4885GSR 4561/4885TXNRD1 4767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.